iiinova — where your digital self keeps evolving

Reposted by LAU Group

Simon Cleary @simoncleary.bsky.social · 01/12/2025

Heading to BSI congress? Plan on attending this all-star session, Thursday at 11AM, chaired by @doreenlau.bsky.social and me!

151

Reposted by LAU Group

Immunotherapy Advances @imtadvances.bsky.social · 06/11/2025

🔬 First head-to-head comparison of nuclear imaging for tumour CD8⁺ T cells shows [⁸⁹Zr]Zr-anti-CD8-IgG2a(silent) & [⁸⁹Zr]Zr-OT-I track T-cell infiltration & migration, aiding immunotherapy strategies. 👉 bit.ly/4ncWCzv #Immunotherapy #CD8Tcells #CancerResearch

013

Reposted by LAU Group

British Society for Immunology @britsocimm.bsky.social · 04/11/2025

🔬 Is seeing believing? Discover how cutting-edge imaging and multi-omics are transforming our understanding of immune cell interactions and spatial immunobiology. Don’t miss this parallel session at #BSI25! Secure your place: bit.ly/3IkxWq8

062

Reposted by LAU Group

Simon Cleary @simoncleary.bsky.social · 25/11/2025

Looking forward to chairing a session with @doreenlau.bsky.social at the British Society for Immunology Congress next week! Great line-up of speakers. Send an email if you would like to meet at or around the conference.

032

LAU Group @doreenlau.bsky.social · 24/09/2025

💡Call for Contributions: "Imaging Immune Cells" part of PIR book series co-edited by Doreen Lau & Santiago F. González. Imaging tech, biological models, AI/image analysis for studying immune processes. More info: doreen.lau@brunel.ac.uk. link.springer.com/series/4983 #immunology #imaging

link.springer.com

Progress in Inflammation Research

This book series addresses all key topical aspects of basic research, therapy and its clinical implications in the field of inflammatory diseases. It provides ...

020

Reposted by LAU Group

Immunotherapy Advances @imtadvances.bsky.social · 06/07/2025

🧩 Antigen presentation is complex - but imaging is bringing clarity. @doreenlau.bsky.social‬ & @timmunologist.bsky.social‬ review how advanced imaging illuminates T-cell–APC interactions, peptide-MHC dynamics, and more in cancer immunity. 📖 bit.ly/3TkIasN #CancerImmunology

0184

Reposted by LAU Group

Immunotherapy Advances @imtadvances.bsky.social · 15/05/2025

Researchers in immune imaging! Submit to our Special Collection: Imaging in Immunotherapy Topics include: 🧬 Molecular imaging 📡 Image-guided drug delivery 🧫 Real-time immune monitoring 📅 Deadline: June 2025 🔗 bit.ly/3GS8t6J

012

LAU Group @doreenlau.bsky.social · 14/05/2025

Great pleasure to be chairing the in vivo modelling of immunotherapy session and working group 2 session at the IMMUNO-model annual conference. Grateful to be part of this vibrant community! x.com/immunomodel/...

x.com

000

LAU Group @doreenlau.bsky.social · 13/05/2025

Excited to share our latest review! We explore how imaging advances understanding of antigen processing and presentation in cancer, key processes shaping T cell responses and immunotherapy outcomes. We highlight imaging tools, biomarkers, and challenges for clinical translation.

academic.oup.com

Imaging antigen processing and presentation in cancer

AbstractIntroduction. Antigen processing and presentation are vital processes of the adaptive immunity. These processes involve a series of intracellular a

032

Reposted by LAU Group

Immunotherapy Advances @imtadvances.bsky.social · 30/04/2025

🧬 Call for Papers: Showcase your work in the Special Collection on Imaging in #Immunotherapy! We're seeking original research, reviews & insights on molecular imaging, drug delivery, and immune monitoring. Submit by June 2025. 🔗 Details: bit.ly/YourSubmissi...

022

Reposted by LAU Group

Immunotherapy Advances @imtadvances.bsky.social · 16/04/2025

Nanobody-based nuclear imaging is redefining cancer care - offering non-invasive, high-precision tools to predict response and guide immunotherapy. Preclinical to clinical progress is accelerating. Read here🔬 bit.ly/4lvxrZ8

022

Reposted by LAU Group

Society for Immunotherapy of Cancer @sitcancer.bsky.social · 21/02/2025

SITC is excited to share the 2024 Year in Review! Discover the breadth and depth of programming from last year! Learn more: www.sitcancer.org/yearinreview... #IO #SITCQuestfor100

012

LAU Group @doreenlau.bsky.social · 20/02/2025

Register now for our IMMUNO-model EU COST Action workshop on "Harmonizing #invivo models of #immunotherapy, past, present and future directions of WG2". Lots of great speakers lined up, don't miss this opportunity to network and learn more about #preclinical models. Info: tinyurl.com/invivoworkshop

immuno-model.eu

IMMUNO-model Workshop: Harmonizing in vivo models of immunotherapy, past, present and future directions of WG2 – IMMUNO-model

000

Reposted by LAU Group

Nature Biotechnology @natbiotech.nature.com · 17/01/2025

Making space for spatial biology in the clinic Spatial transcriptomics methods have been slow to move into clinical practice, but spatial proteomics are cheaper and more scalable, and could progress faster go.nature.com/3PoWPkz

03519

Reposted by LAU Group

Nature Cancer @natcancer.nature.com · 20/12/2024

⭐️If you haven't yet done so, check out our 2024 year-in-review Focus Issue now! 🔗https://nature.com/collections/chiegfhchj Featuring: *Editorial on 2024 #cancerresearch highlights *#newPIs Viewpoint *#AI and #spatialomics in #oncology *(CAR-)T cell therapies in cancer *12 Research Highlights

0154

LAU Group @doreenlau.bsky.social · 10/01/2025

Brunel-British Council #Scholarships for #WomeninSTEM is open for application! Great opportunity for #SoutheastAsia students to study abroad in the UK and engage in #cancerresearch through our MSc Mechanisms and Therapy in Cancer programme: tinyurl.com/brunelbritishcouncil

tinyurl.com

British Council Scholarships for Women in STEM 2025/26

British Council Scholarships for Women in STEM 2025/26 - Malaysia, Myanmar, Philippines and Vietnam

031

LAU Group @doreenlau.bsky.social · 10/01/2025

#CallForPapers by British Society for Immunology journal Immunotherapy Advances. Don't miss this great opportunity to showcase your research in #imaging #immunology #immunotherapy and catalyse new avenues for collaboration!

041